Drug intelligence / Profile preview

ExoPowder

Development stage
Preclinical
Lead developer
EVMed
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical, Injection
01

Overview

ExoPowder is an exosome-based biologic product developed by Evomed (Suzhou EVMedpro Technology Co., Ltd.). It is a powder-form formulation of exosomes designed for research and potential therapeutic applications, offering improved stability and ease of storage compared to liquid formulations. Exosomes are extracellular vesicles that mediate intercellular communication by transferring proteins, lipids, and nucleic acids between cells. Evomed utilizes a suite of proprietary technologies—ExoPlus, ExoCell, ExoPure, and ExoTest—to produce and characterize these exosome products. While the company does not maintain a traditional clinical pipeline with specific disease indications, ExoPowder is positioned as a high-potency raw material or finished product for use in regenerative medicine, aesthetics, and other clinical research fields.

Brand names
ExoPowder
Other names
ExoPowder-Evomed-exosome product-biologic

Beyond the preview

Go deeper on ExoPowder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ExoPowder.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call